These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3931827)

  • 1. Valuation of life in long run health care programmes.
    West RR
    Br Med J (Clin Res Ed); 1985 Oct; 291(6502):1139-41. PubMed ID: 3931827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect cost in economic evaluation: the opportunity cost of unpaid inputs.
    Posnett J; Jan S
    Health Econ; 1996; 5(1):13-23. PubMed ID: 8653189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
    Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
    Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An economic appraisal of alternative pre-natal screening programmes for Down's syndrome.
    Shackley P; McGuire A; Boyd PA; Dennis J; Fitchett M; Kay J; Roche M; Wood P
    J Public Health Med; 1993 Jun; 15(2):175-84. PubMed ID: 7688977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic benefits of fertility control: a critical analysis of the investment approach.
    Badari VS
    J Inst Econ Res; 1977; 11(1/2):17-27. PubMed ID: 12261074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A benefit-cost analysis of family planning services in Iowa.
    Levey LM; Nyman JA; Haugaard J
    Eval Health Prof; 1988 Dec; 11(4):403-24. PubMed ID: 10312809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing the birth of infants with Down's syndrome: a cost-benefit analysis.
    Hagard S; Carter FA
    Br Med J; 1976 Mar; 1(6012):753-6. PubMed ID: 130957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.
    Grosse SD; Thompson JD; Ding Y; Glass M
    Milbank Q; 2016 Jun; 94(2):366-91. PubMed ID: 27265561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discounting in health care decision-making: time for a change?
    Sheldon TA
    J Public Health Med; 1992 Sep; 14(3):250-6. PubMed ID: 1419202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime earnings patterns, the distribution of future Social Security benefits, and the impact of pension reform.
    Bosworth B; Burtless G; Steuerle E
    Soc Secur Bull; 2000; 63(4):74-98. PubMed ID: 11641991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Economic analyses of health care. Cost benefit analyses promote better use of resources].
    Kristiansen IS
    Tidsskr Nor Laegeforen; 1990 Aug; 110(18):2377-81. PubMed ID: 2120789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical guide for calculating indirect costs of disease.
    Koopmanschap MA; Rutten FF
    Pharmacoeconomics; 1996 Nov; 10(5):460-6. PubMed ID: 10172868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On future non-medical costs in economic evaluations.
    Liljas B; Karlsson GS; Stålhammar NO
    Health Econ; 2008 May; 17(5):579-91. PubMed ID: 17787027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost analysis of a primary health centre in northern India.
    Anand K; Kapoor SK; Pandav CS
    Natl Med J India; 1993; 6(4):160-3. PubMed ID: 8401192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care.
    O'Brien B; Gafni A
    Med Decis Making; 1996; 16(3):288-99. PubMed ID: 8818128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method to value real options in health care: the case of a multicohort human papillomavirus vaccination strategy.
    Favato G; Baio G; Capone A; Marcellusi A; Saverio Mennini F
    Clin Ther; 2013 Jul; 35(7):904-14. PubMed ID: 23806328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Estimation and Inclusion of Presenteeism Costs in Applied Economic Evaluation: A Systematic Review.
    Kigozi J; Jowett S; Lewis M; Barton P; Coast J
    Value Health; 2017 Mar; 20(3):496-506. PubMed ID: 28292496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic-demographic interactions and the impact of investments in population control.
    Paqueo VB
    Philipp Econ J; 1981; 20(3-4):257-76. PubMed ID: 12266152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.